Research Statement
Rene Hurlemann completed his M.D. at the University of Bonn Medical School, Germany, in 2001, and received his M.Sc. (2006) and Ph.D. (2007) from Maastricht University, The Netherlands. Currently, he is head of the Medical Psychology Division and vice chair of the Department of Psychiatry at the University of Bonn. As associate professor and clinician scientist, he is committed to research in the field of psychiatric neuroscience, with a methodological emphasis on pharmacological fMRI and MRI-navigated TMS. He is principle investigator of the �Neuromodulation of Emotion (NEMO)� research group, for which he obtained a 1.3 million Euro starting grant in 2010. His current research is focused on developing experimental therapies for anxiety, autism, depression, and (prodromal) schizophrenia. He is (associate) member of several professional societies, including the American College of Neuropsychopharmacology (ACNP), the European College of Neuropsychopharmacology (ECNP), the Society for Neuroscience (SfN), and the Society of Biological Psychiatry (SoBP).
